Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Ion Chromatography Method Development – V 2.0

Posted on By

Analytical Method Development: SOP for Ion Chromatography Method Development – V 2.0

Standard Operating Procedure for Ion Chromatography Method Development in Pharmaceutical Analysis


Department Analytical Method Development
SOP No. SOP/AMD/171/2025
Supersedes SOP/AMD/171/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

To establish a detailed and standardized procedure for the development and validation of Ion Chromatography (IC) methods used to detect and quantify ionic impurities, including anions,

cations, and organic acids, in pharmaceutical substances and dosage forms.

2. Scope

This SOP applies to the Analytical Method Development (AMD) department for the implementation of ion chromatography techniques in compliance with ICH and pharmacopeial guidelines for raw materials, APIs, intermediates, and finished products.

3. Responsibilities

  • Analytical Scientist: Develops and validates IC methods, ensures suitability of reagents and columns.
  • Instrument Analyst: Operates IC equipment, monitors performance, and records system parameters.
  • QA Officer: Reviews development data, validation reports, and ensures regulatory compliance.
  • Head – AMD: Provides oversight and final approval of methods for use in regulated analysis.
See also  Analytical Method Development: SOP for Intermediate Precision Evaluation - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for the scientific soundness, compliance, and release of IC methods in routine quality control and regulatory submissions.

5. Procedure

5.1 Preliminary Method Design

  1. Identify target analytes (e.g., chloride, sulfate, nitrate, sodium, ammonium, acetate).
  2. Select detection technique: conductivity detector (with or without suppressor), UV, or PAD (Pulsed Amperometric Detection) for carbohydrates.
  3. Choose appropriate IC mode: anion exchange or cation exchange.

5.2 Column and Mobile Phase Selection

  1. Choose appropriate column (e.g., Dionex IonPac AS22 for anions, CS12A for cations).
  2. Prepare eluent based on analyte type:
    • Anion eluent: carbonate/bicarbonate solution (3.2 mM Na2CO3, 1.0 mM NaHCO3)
    • Cation eluent: methanesulfonic acid (MSA) solution (20 mM)
  3. Use degassed and filtered deionized water for mobile phase preparation.

5.3 Instrument Configuration

  1. Install and condition the column as per manufacturer instructions.
  2. Set IC system parameters:
    • Flow rate: 1.0 mL/min
    • Column temp: 30°C
    • Injection volume: 25 µL
    • Suppressor current: as recommended
  3. Calibrate conductivity detector or UV detector at the required wavelength (for UV-absorbing species).
See also  Analytical Method Development: Development of FTIR Fingerprint Spectrum - V 2.0

5.4 Sample and Standard Preparation

  1. Dissolve known quantity of sample in ultrapure water (or diluent).
  2. Filter through 0.22 µm membrane filter and inject immediately.
  3. Prepare calibration standards at 5 levels (e.g., 25, 50, 75, 100, 125% of target concentration).

5.5 System Suitability and Calibration

  1. Inject system suitability solution containing target ions.
  2. Verify:
    • Resolution between critical pairs ≥ 1.5
    • Retention time RSD ≤ 1.0%
    • Linearity R² ≥ 0.995
  3. Document in Annexure-1: System Suitability Log.

5.6 Method Validation

  1. Validate as per ICH Q2(R2):
    • Specificity – No interference at analyte RT
    • Linearity – R² ≥ 0.995
    • Accuracy – Recovery 95–105%
    • Precision – RSD ≤ 2%
    • LOD/LOQ – Based on S/N ratio 3:1 and 10:1
    • Robustness – Slight variations in flow, eluent, temperature
  2. Record findings in Annexure-2: Validation Summary Sheet.

6. Abbreviations

  • IC: Ion Chromatography
  • RT: Retention Time
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • RSD: Relative Standard Deviation
  • SOP: Standard Operating Procedure
See also  Analytical Method Development: SOP for Linearity and Range Evaluation - V 2.0

7. Documents

  1. System Suitability Log – Annexure-1
  2. Validation Summary Sheet – Annexure-2
  3. Calibration Curve Log – Annexure-3

8. References

  • ICH Q2(R2) – Validation of Analytical Procedures
  • USP <1065> – Ion Chromatography
  • EP 2.2.28 – Ion Chromatography
  • FDA Guidance on Elemental and Ionic Impurities

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: System Suitability Log

Parameter Result Acceptance Status Analyst
Resolution 2.1 ≥ 1.5 Pass Sunita Reddy
RT RSD 0.7% ≤ 1.0% Pass Sunita Reddy

Annexure-2: Validation Summary Sheet

Parameter Result Criteria Status
Linearity R² = 0.9987 ≥ 0.995 Pass
Recovery 97.4% 95%–105% Pass

Annexure-3: Calibration Curve Log

Concentration (ppm) Peak Area Analyst
10 1453 Rajesh Kumar
25 3612 Rajesh Kumar
50 7435 Rajesh Kumar

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Expanded buffer selection and annexure section Annual SOP Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Creams: SOP for Archiving QA Documents and Records – V 2.0
Next Post: Biosimilars: SOP for Batch Documentation Approval – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version